CTOs on the Move

ACUFOCUS, Inc.

www.acufocus.com

 
ACUFOCUS, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acufocus.com
  • 32 Discovery Ste 200
    Irvine, CA USA 92618
  • Phone: 949.585.9511

Executives

Name Title Contact Details

Similar Companies

Fullpower

Fullpower is the leader for cloud-based IoT smart-home and wearable solutions powered by AI, machine-learning and data science. With more than 125 patents, the Fullpower IP portfolio covers the AI-powered Sleeptracker® and the MotionX® IoT technology platforms for the Smart-Home and wearable. Fullpower`s business model is to license technology and IP to brand leaders such as Nike, BeautyRest, Amazon, Movado, Serta and others. Founded by Philippe Kahn, creator of the first camera-phone and based in Silicon Valley, the Fullpower team is passionate about technology craftsmanship, innovation, and the global AI-IoT paradigm shift.

Initia Medical

Initia Medical is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Health Care Products

Canadian Health Care Products is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

canada care medical

canada care medical is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.